Carey Thomas P 4

4 · BROADRIDGE FINANCIAL SOLUTIONS, INC. · Filed Dec 4, 2025

Form 4

Period: 2025-12-03

Corporate VP

Transactions

Exercise/Conversion
Common Stock
2025-12-03$148.07/sh+6,000$888,420→ 12,077 total
Exercise/Conversion
Common Stock
2025-12-03$93.88/sh+4,163$390,822→ 16,240 total
Sale
Common Stock
2025-12-03$229.26/sh−1,150$263,644→ 15,090 total
Sale
Common Stock
2025-12-03$229.26/sh−3,516$806,063→ 11,574 total
Sale
Common Stock
2025-12-03$229.26/sh−5,548$1,271,911→ 6,026 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-03−4,163→ 0 total
Exercise: $93.88From: 2019-02-12Exp: 2028-02-12→ Common Stock (4,163 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-03−6,000→ 8,548 total
Exercise: $148.07From: 2022-02-12Exp: 2031-02-12→ Common Stock (6,000 underlying)

Footnotes (1)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.89 - $229.71, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Documents

1 file